Physician profile
Ellen G Smith
NPI 1710625223
$3,004.99
in general payments reported to CMS, 2019-2025
12 companies · $2,050 in 2025
The $2,050 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $153 · 2023: $369 · 2024: $434 · 2025: $2,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,816 · Travel and Lodging: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,815.81 |
| Travel and Lodging | $1,036.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,639.99 | 2022-2025 | Rocklatan, Precision7, Total30 |
| Bausch & Lomb Americas INC. | $573.72 | 2022-2025 | Miebo, Infuse, Xiidra |
| Abbvie INC. | $296.96 | 2023-2025 | Lumigan, Alphagan P |
| Tarsus Pharmaceuticals, INC. | $170.60 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $82.70 | 2024-2025 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $62.99 | 2025 | |
| Coopervision INC. | $51.41 | 2023-2024 | Myday Contact Lens |
| Harrow Eye, LLC | $40.92 | 2024-2025 | Vevye |
| Rxsight INC | $35.28 | 2023-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Rayner Intraocular Lenses Limited | $22.92 | 2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Dompe US, INC. | $13.94 | 2024 | Oxervate |
| New World Medical,INC. | $13.56 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.